Advertisement
Research Article

A Replicating Cytomegalovirus-Based Vaccine Encoding a Single Ebola Virus Nucleoprotein CTL Epitope Confers Protection against Ebola Virus

  • Yoshimi Tsuda,

    Affiliation: Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America

    X
  • Patrizia Caposio,

    Affiliation: Vaccine and Gene Therapy Institute, Oregon Health and Science University, Portland, Oregon, United States of America

    X
  • Christopher J. Parkins,

    Affiliation: Vaccine and Gene Therapy Institute, Oregon Health and Science University, Portland, Oregon, United States of America

    X
  • Sara Botto,

    Affiliation: Vaccine and Gene Therapy Institute, Oregon Health and Science University, Portland, Oregon, United States of America

    X
  • Ilhem Messaoudi,

    Affiliation: Vaccine and Gene Therapy Institute, Oregon Health and Science University, Portland, Oregon, United States of America

    X
  • Luka Cicin-Sain,

    Affiliation: Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany

    X
  • Heinz Feldmann,

    Affiliation: Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America

    X
  • Michael A. Jarvis mail

    jarvismi@ohsu.edu

    Affiliations: Vaccine and Gene Therapy Institute, Oregon Health and Science University, Portland, Oregon, United States of America, Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, United States of America

    X
  • Published: August 09, 2011
  • DOI: 10.1371/journal.pntd.0001275

Reader Comments (0)

Post a new comment on this article